Building on our experience at previous law firms and in-house, Denoon Legal has acted on a number of high profile M&A transactions (including IPOs on various stock exchanges). Normally Denoon Legal acts in these matters as a specialist adviser alongside another law firm as co-counsel.

Some of the more novel transactions have included:

• a number of high profile and high value acquisitions of clinics;
• an innovative purchase of a portfolio of medicinal product brands, regulatory approvals and regulatory documentation; and
• the sale of a pharmaceutical and medical technology business to Watson (now Actavis) for up to $300M.